News
-
How can you further improve healthcare with the use of ‘big data’? That question is central to many scientific studies worldwide. At Maastricht University, the research group led by Professor of Clinical Data Sciences André Dekker is also working on answers to this question.
-
The healthy primary school is the future. This is evident from the choice of the municipalities of Brunssum, Heerlen, Sittard-Geleen and Maastricht to launch Healthy Primary School of the Future projects.
-
SHE Collaborates will receive €225,000 from Nuffic for three projects in Jemen and South-Sudan.
-
Pioneering research could prevent lymphoedema (PhD Maarten Beek).
-
Certain types of chemotherapy cause a greater degree of nerve damage than was previously thought (PhD conferral Tonneke Beijers).
-
The selective withdrawal of red blood cells as a treatment for haemochromatosis (iron overload) is an effective and patient-friendly alternative to phlebotomy (bloodletting) (PhD conferral Eva Rombout).
-
A new detection technique – injecting tracers into ovarian ligaments – helps to carry out a sentinel lymph node procedure in ovarian cancer. This leads to greater accuracy in detecting lymph node metastases and also leads to fewer side effects for patients.
-
On 1 November, Maastricht University has appointed Dr Fiona Godlee, editor in chief of The BMJ (formerly the British Medical Journal), as honorary professor on behalf of national research school CaRe (Netherlands School for Primary Care Research).
-
Patients with metastatic breast cancer have a better life expectancy if they are treated with hormone therapy (MUMC+ news).